Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Brainstorm Cell Therapeutics Inc. (BCLI) had Return on Equity of 27.38% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-2.11M |
|
-- |
|
-- |
|
$2.05M |
|
$-2.05M |
|
$-0.06M |
|
$-2.11M |
|
$-2.11M |
|
$-2.11M |
|
$-2.11M |
|
$-2.11M |
|
$-2.11M |
|
$-2.05M |
|
$-2.00M |
|
11.01M |
|
11.01M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$0.51M |
|
$0.28M |
|
$0.87M |
|
$1.38M |
|
$9.02M |
|
-- |
|
$0.05M |
|
$9.07M |
|
$-7.69M |
|
$-7.69M |
|
$-7.69M |
|
11.04M |
|
| Cash Flow Statement Financials | |
$-6.24M |
|
$0.00M |
|
$6.10M |
|
$0.37M |
|
$0.24M |
|
$-0.14M |
|
$1.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.06 |
|
-- |
|
-- |
|
-- |
|
-0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.24M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
27.38% |
27.38% |
|
-152.61% |
|
27.38% |
|
$-0.70 |
|
$-0.57 |
|
$-0.57 |
|